Fore Biotherapeutics
Operator of a clinical-stage biotechnology company intended to develop selective medicines for functionally and gnomically defined cancer patients. The company's clinical-stage drug development aids i...
Valuation
$198.2M
Latest known
Share Price
N/A
Total Raised
$190.7M
Last Round
N/A